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SHORT RESEARCH ARTICLE
Fecal transplantation does not transfer either susceptibility or
resistance to food borne listeriosis in C57BL/6 and BALB/c/By
 mice [v1; ref status: indexed, http://f1000r.es/1jt]
Tanya Myers-Morales,  Kate M Bussell, Sarah EF D'Orazio
Dept. of Microbiology, Immunology & Molecular Genetics, University of Kentucky, Lexington, KY, USA
Abstract
The composition of the intestinal microbiota has wide reaching effects on the
health of an individual, including the development of protective innate immune
responses.  In this report, a fecal transplantation approach was used to
determine whether resistance to food borne listeriosis was dependent on the
murine gut microbiota.  Transplantation of BALB/c/By feces did not increase the
susceptibility of C57BL/6 mice to  infection.   Likewise,Listeria monocytogenes
transplantation of C57BL/6 fecal matter did not enhance the resistance of
BALB/c/By mice.  Thus, intestinal microbiota composition is not a key factor
that confers either susceptibility or resistance to food borne listeriosis in mice.
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Introduction
Listeria monocytogenes is a Gram-positive, facultative intracellular 
bacterial species that can readily adapt to a variety of environmental 
stresses, including high salt concentration, low pH, and refrigera-
tion1. In humans, ingestion of L. monocytogenes-contaminated food 
results in a wide spectrum of clinical outcomes, ranging from mild, 
self-limiting gastroenteritis to lethal meningoencephalitis2. The 
majority of serious infections occur in patients with some degree 
of immune compromise, but the exact host factors that determine 
susceptibility to these infections are not well understood.
L. monocytogenes infection can be established in almost any out-
bred or inbred strain of laboratory mice, but there are significant 
differences among mouse strains for both morbidity and mortal-
ity. C57BL/6 mice are one of the most resistant strains, and can 
readily clear L. monocytogenes infection, while BALB/c mice are 
highly susceptible to developing life-threatening systemic listeri-
osis. These differences in host susceptibility hold true whether mice 
are infected by the intravenous route3,4, via intragastric inoculation5, 
or by ingestion of contaminated food6.
Genetic analysis of laboratory mouse strains has defined a number 
of alleles that can be either deleterious or beneficial to mice during 
L. monocytogenes infection7–9, however, no single trait appears to be 
entirely responsible for the susceptibility or resistance phenotype. 
Instead, the ability to clear a bacterial infection is likely to depend 
upon complex interactions between multiple host factors. It was also 
recently shown that a novel mechanism, unrelated to specific gene 
loci, could account for the majority of the difference in host suscep-
tibility to infection between two mouse strains. Willing et al. dem-
onstrated that the enhanced susceptibility of C3H/HeJ mice to oral 
Citrobacter infection could be completely transferred to resistant 
NIH Swiss mice10. To do this, they depleted the gut microbiota of 
the resistant NIH Swiss mice and repopulated the intestinal tracts of 
those animals with fecal matter harvested from susceptible C3H/HeJ 
mice. Their striking results implied that varying gut microbiota com-
positions could underlie many previously observed differences in host 
susceptibility to infection with a variety of orally acquired bacterial 
pathogens.
The mouse strains used by Willing et al. came from two different 
vendors, so it is not surprising that the composition of the gut mi-
crobiota in those animals differed significantly. However, the pre-
dominant organisms found in the gastrointestinal tract can differ, 
even for mice housed in the same facility, particularly when the 
mice are altered in specific components of the immune system. For 
example, the intestinal microbiota was reported to differ compared 
with parental control strains in mice expressing human alpha de-
fensin11, or in mice lacking IL-1012, IL-2213, neutrophil elastase14, 
NLRP615, or TLR516. In fact, it has been shown that the presence or 
absence of a single type of bacteria in the gut can dramatically alter 
the development of innate immune responses and inflammatory dis-
ease17–19. In this report, we used the fecal transplantation approach 
of Willing et al. to test the hypothesis that the murine intestinal 
microbiota can at least partially mediate either the susceptibility of 
BALB/c/By mice or the resistance of C57BL/6 mice to food borne 
L. monocytogenes infection.
Materials and methods
Mice
Female C57BL/6/J (B6) and BALB/c/By/J (By) mice were pur-
chased from The Jackson Laboratory (Bar Harbor, ME) at 4 weeks 
of age and then housed at the University of Kentucky for 2 weeks in a 
specific-pathogen free facility with a 14 h light cycle (12 am–2 pm) 
and a 10 h dark cycle (2 pm–12 am). Groups of four mice were housed 
in microisolator cages (Inc., Allentown, NJ) lined with coarse grade 
Sani-Chip bedding (PJ Murphy Forest Products, Montville, NJ). All 
procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC) at the University of Kentucky.
Preparation of fecal matter
Prior to each fecal transfer treatment, fecal pellets were collected 
from 3–4 donor mice, pooled together and weighed, and then placed 
in 0.25–1.0 ml of transfer buffer sterile filtered 0.05% cysteine HCl 
(Calbiochem/EMD Millipore, Billerica, MA) in Dulbecco’s Phos-
phate Buffered Saline (PBS; Life Technologies, Grand Island, NY), 
as described previously10. The final volume was adjusted to give 
120 mg feces per ml. The fecal pellets were mashed with sterile 
wooden toothpicks (Wesco Enterprises, Santa Fe Springs, CA), and 
then vortexed (Vortex Genie; Scientific Industries, Bohemia, NY) at 
maximum speed for 1 min. The fecal matter was centrifuged (Ep-
pendorf 5417C; Hauppauge, NY) for 3 min. at 800 × g and the 
supernatant was used for transplantation into mice.
Fecal transplantation
The endogenous gut microbiota of 6 week old mice was depleted by 
treating with a single dose of streptomycin (Sigma-Aldrich, St. Lou-
is, MO). The antibiotic was suspended in sterile water at 500 mg/ml 
and 50 µl was placed directly in the oral cavity of each mouse. After 
the oral antibiotic treatment, mice were housed on raised wire floor-
ing (# 3 mesh; Allentown) to prevent coprophagy. Fecal transplants 
were initiated 24 h later by placing 50 µl of the donor fecal matter 
directly into the oral cavity of the recipient mice (n=4 per group). 
Control groups of mice (n=4) were given 50 µl of transfer buffer 
alone. As shown in Figure 1B and Figure 2B, all mice received fecal 
transplants 24 and 48 hours after the streptomycin treatment. After 
the second fecal transplant, the wire flooring units were removed 
from the cages. Each group of mice (n=4) received a total of four 
additional treatments over the next 6–7 days (see Figure 1A and 
Figure 2A), prior to oral challenge with L. monocytogenes.
Quantification of fecal microbiota
Stool samples were collected both before and after streptomycin 
treatment. Three fecal pellets per mouse were placed in a microcen-
trifuge tube (VWR; Radnor, PA) containing 1 ml of sterile water. 
The pellets were mashed with a sterile wooden toothpick, vortexed 
at maximum speed for 1 min. and centrifuged at 800 × g for 3 min. 
The total number of aerobic colony forming units (CFU) was deter-
mined by plating serial dilutions of the supernatant on Brain Heart 
Infusion (BHI) agar (Difco; BD Diagnostics, Franklin Lakes, NJ) 
and incubating at 37°C overnight.
Food borne Listeria challenge
After completing a total of 6 oral treatments with either donor fe-
cal material or transfer buffer alone, all mice were denied food (but 
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given unrestricted access to water) and placed on raised wire flooring 
(to prevent coprophagy) for 24 h. Aliquots of intestinally passaged 
L. monocytogenes EGDe InlAm (generously provided by Wolf Dieter 
Schubert, Braunschweig, Germany) were prepared and grown as 
previously described6. Bacteria were washed once with sterile PBS, 
suspended in 40% melted salted butter (Kroger; Cincinnati, OH) in 
PBS, and then 5 µl of this mixture was used to saturate a small cube 
of white bread (Kroger). At the onset of the dark cycle, each mouse 
was placed in an empty cage with one L. monocytogenes-contami-
nated bread piece and was observed until it picked up the bread and 
consumed it entirely as previously described20. After ingesting the 
L. moncytogenes-contaminated bread, each mouse was returned to 
its original cage and was given unrestricted access to mouse chow 
and water for the duration of the experiment (5 days).
Quantification of Listeria tissue burdens
Five days post-infection, all mice were euthanized by cervical dis-
location and the organs were harvested aseptically as previously 
described20. The total cell-associated L. monocytogenes in the colon 
was determined by extensively flushing the tissue with sterile PBS 
to remove lumenal bacteria and then homogenizing for 1 min. as 
previously described6,20. Spleens and livers were collected in 2 ml of 
sterile water and homogenized for 30 sec. using a PowerGen 1000 
homogenizer (IKA Works, Wilmington, NC). Gall bladders were 
placed in microcentrifuge tubes containing 1 ml of sterile water, 
ruptured with sterile scissors (VWR, Radnor, PA), and vortexed at 
maximum speed for 1 min. Serial dilutions of each tissue homogen-
ate were prepared in sterile water and then plated on BHI/L+G (BHI 
agar supplemented with 15 g/L LiCl (Sigma-Aldrich) and 10 g/L 
glycine (Calbiochem), a selective medium that inhibited the growth 
of intestinal microbiota6,20. Colony forming units (CFU) were ob-
served after 48 h growth at 37°C and the number of colonies was 
multiplied by the dilution factor and the total volume of the sample 
to give the total number of CFU per tissue.
Statistics
Unpaired t tests were performed using Prism 5 software for Macin-
tosh (Graph Pad). P values less than 0.05 were considered signifi-
cant and are indicated as follows: *, P < 0.05; **, P < 0.01; ***, 
P < 0.001; ****, P < 0.0001; ns, not significant.
Figure 1. Transplantation of fecal matter from C57BL/6 (B6) 
mice to BALB/c/By (By) mice does not confer resistance to 
L. monocytogenes. (A) The experimental design for four groups 
of mice is shown. Mock-treated mice received oral treatments with 
buffer alone and maintained their original microbiota. Streptomycin-
treated mice received a total of 6 fecal transfers over a 9 day period. 
On day 10, food was restricted and all mice were placed on raised 
wire flooring for the duration of the experiment. (B) The efficiency of 
streptomycin pre-treatment was evaluated by monitoring the amount 
of aerobic CFU shed in the feces. Arrows indicate days of either 
antibiotic treatment (Strep) or fecal transplants (FT). Mean values 
± SEM for groups of 8 mice are shown. (C) Mean values ± SEM 
(n=8) for total L. monocytogenes CFU in spleen, liver, or gall bladder 
and cell-associated CFU in the colon were determined 5 days post 
infection. Asterisks indicate mean values significantly different from 
the mock-treated By group as determined by unpaired t-test. Pooled 
data from two separate experiments comprising 4 mice per group 
is shown.
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Results
Fecal transplantation does not transfer the resistance 
phenotype of C57BL/6 mice to BALB/c/By mice
To test the hypothesis that resistance to listeriosis could be medi-
ated by gut microbiota, fecal matter was recovered from resistant 
C57BL/6 mice and used to repopulate the intestinal lumens of sus-
ceptible BALB/c/By mice (Figure 1A). Groups of BALB/c mice 
were given a single oral dose of streptomycin to eradicate the exist-
ing microbiota. One day later, the mice began a series of six oral 
treatments with C57BL/6 fecal matter. The efficacy of the antibi-
otic treatment was confirmed by plating stool samples from each 
of the recipient animals. As shown in Figure 1B, the number of 
bacteria that could be recovered during aerobic growth decreased 
by more than 5 logs. From 24 to 48 h post-antibiotic treatment, the 
number of CFU in the stool samples was below the limit of detec-
tion (10 CFU) in the majority of the animals (Figure 1B). By 72 h 
post-antibiotic treatment, after two fecal transplants, the number of 
CFU present in the stool samples had recovered to pre-treatment 
levels. To ensure that the transferred microbiota persisted, each 
animal received four additional fecal transplants prior to oral 
L. monocytogenes challenge (Figure 1A).
Groups of BALB/c/By mice transplanted with C57BL/6 micro-
biota, or repopulated with BALB/c/By fecal matter as a control, 
were then infected with L. monocytogenes via the natural feeding 
route. The bacterial burdens in the colon, spleen, liver, and gall 
bladder were determined 5 days post-infection and compared to 
groups of BALB/c/By and C57BL/6 mice that were mock-treated 
(no fecal transplantation; see Figure 1A). As expected, C57BL/6 
mice had 30 to 1000-fold fewer L. monocytogenes in each tissue 
examined compared with BALB/c/By mice (Figure 1C). In con-
trast, there was no significant difference between the groups of 
BALB/c/By mice that received C57BL/6 fecal transplants and the 
BALB/c/By mice that were mock treated. Thus, fecal transplanta-
tion did not cause BALB/c/By mice to become more resistant to oral 
L. monocytogenes challenge, suggesting that the gut microbiota 
alone does not contribute significantly to the resistance phenotype 
observed in C57BL/6 mice.
Figure 2. Transplantation of fecal matter from BALB/c/By (By) 
mice to C57BL/6 (B6) mice does not enhance susceptibility to 
food borne listeriosis. (A) The experimental design for four groups 
of mice is shown. Mock-treated mice received oral treatments with 
buffer alone and maintained their original microbiota. Streptomycin-
treated mice received a total of 6 fecal transfers over an 8 day period. 
On day 9, food was restricted and all mice were placed on raised 
wire flooring for the duration of the experiment. (B) The efficiency 
of the streptomycin pre-treatment was evaluated by monitoring the 
amount of aerobic CFU shed in the feces. Mean values ± SEM for 
groups of 8 mice are shown. Arrows indicate days of either antibiotic 
treatment (Strep) or fecal transfers (FT). (C) Mean values ± SEM 
(n=8) for total L. monocytogenes CFU in spleen, liver, or gall bladder 
and the cell-associated CFU in the colon were determined 5 days 
post infection. Asterisks indicate mean values significantly different 
from the mock-treated C57BL/6 group as determined by unpaired 
t-test. Pooled data (n=8) from two separate experiments (n=4 per 
group in each) is shown.
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BALB/c/By fecal transplants do not render C57BL/6 mice 
more susceptible to gastrointestinal infection
Susceptibility and resistance to infection are separate traits that are 
often linked to distinct gene loci. To test the alternate hypothesis 
that bacteria present in the gut microbiota could confer susceptibil-
ity to listeriosis, BALB/c/By feces was transplanted into C57BL/6 
mice (Figure 2A). Groups of C57BL/6 mice were pre-treated with 
streptomycin and then given 6 oral treatments with BALB/c/By fe-
cal matter. Control groups received C57BL/6 feces or were mock 
treated (Figure 2A). Again, the streptomycin treatment efficiently 
cleared the vast majority of the aerobic bacteria present in the gut 
lumen within 24 h, and fecal transplantation restored the level of the 
intestinal microbiota within 3 days (Figure 2B).
The mice were infected with L. monocytogenes by ingestion of con-
taminated food, and the number of CFU present in the gut and in pe-
ripheral tissues was determined 5 days later. Mock-treated C57BL/6 
mice had 1000-fold less L. monocytogenes than BALB/c/By mice 
in the colon (Figure 2C), the site within the intestines which was 
previously shown to allow for the greatest growth and persistence 
of L. monocytogenes after oral infection6. Transfer of BALB/c/By 
microbiota did not enhance the ability of L. monocytogenes to colo-
nize the colon, as there was no significant difference between the 
B6 + By group and mock-treated C57BL/6 mice (Figure 2C).
In the food borne model of listeriosis, the spleen and liver are not 
colonized until 48 h post-ingestion and bacteria begin to appear in 
the gall bladder 3–4 days post-infection6. Thus, bacterial burdens 
5 days post-infection reflect both the ability of L. monocytogenes 
to disseminate from the gut, and bacterial replication within these 
tissues. As shown in Figure 2C, resistant C57BL/6 mice had at 
least 1000-fold fewer L. monocytogenes in the spleen and liver 
and approximately 100,000-fold less bacteria in the gall bladder 
compared with mock-treated BALB/c/By mice. Transplantation of 
BALB/c/By fecal matter did not result in an increase in bacterial 
loads in either the liver or the gall bladder of C57BL/6 mice (B6 
+ By group; Figure 2C). Fecal transplants did result in a slight in-
crease in the number of L. monocytogenes recovered from spleens 
of C57BL/6 mice, however, a similar increase was observed wheth-
er the mice were transplanted with BALB/c/By feces or re-popu-
lated with C57BL/6 fecal matter. Together, these results suggest 
that the gut microbiota of BALB/c/By mice cannot independently 
enhance susceptibility to food borne listeriosis.
Discussion
Differing levels of resistance to infection with bacterial pathogens 
such as L. monocytogenes are well documented in mice3–6. Until 
recently, it was assumed that specific DNA loci were responsible, 
and that different combinations of susceptibility and resistance 
alleles would result in varying degrees of infection in any given 
mouse strain21. A recent report by Willing et al. shattered this para-
digm by using a fecal transplantation approach to demonstrate that 
the gut microbiota alone could confer resistance to Citrobacter 
rodentium infection10. In this study, we used a similar approach 
to determine whether the composition of the intestinal microbiota 
could alter the dynamics of L. monocytogenes infection in mice. 
Using a food borne model of listeriosis20, we showed that trans-
plantation of BALB/c/By feces into C57BL/6 mice did not make 
the mice more susceptible to infection. Likewise, transplantation 
of C57BL/6 fecal matter was unable to enhance the resistance of 
BALB/c mice.
A key factor required for C. rodentium infection appears to be the 
induction of a strong Th1 type inflammatory response in the intes-
tines. Lupp et al. previously showed that the inflammation itself 
significantly altered the composition of the gut microbiota in a way 
that promoted the aerobic outgrowth of both endogenous mem-
bers of the Enterobacteriaceae as well as the introduced pathogen 
C. rodentium12. L. monocytogenes is an invasive pathogen, and thus, 
may not need to overcome colonization resistance or compete with 
the microbiota for growth in the intestinal lumen in order to es-
tablish an infection. L. monocytogenes can cross the gut mucosa 
using M cells or via a “zipper” mechanism of uptake into entero-
cytes and goblet cells that is dependent on interactions between the 
bacteria surface protein InlA and E-cadherin on the host cell22,23. 
Both mechanisms result in rapid translocation to the lamina propria 
where the bacteria replicate extensively before disseminating to pe-
ripheral tissues to cause systemic listeriosis6. Thus, if even a few 
L. monocytogenes can translocate across the mucosal barrier, the 
infection will be maintained, even if there is very little growth of 
the bacteria in the gut lumen.
The fecal transplantation approach is a useful way to significantly 
alter the gut microbiota, but it does not completely eliminate the 
native bacterial populations present in any given mouse. A single 
dose of streptomycin can transiently reduce, by approximately 
90%, the density of bacteria recovered using anaerobic culture con-
ditions24, and the intestinal microbiota will return to normal levels 
within 3–4 days. Willing et al. used 16S RNA analysis to show 
that within 4–5 days of fecal transplantation, mice had an altered 
microbiota composed of microbial families from both the donor 
and recipient mouse strains, with ratios that strongly reflected the 
donor strain10. Given these parameters, the fecal transplantation ap-
proach is most informative if the presence of a transferred micro-
bial species confers a particular phenotype, even when the original 
microbiota is not completely displaced. Thus, we cannot rule out 
the possibility that small numbers of native microbial species not 
eliminated by streptomycin treatment could confer some degree of 
susceptibility to BALB/c/By mice or resistance to C57BL/6 mice. 
However, the results shown here clearly suggest that the composi-
tion of the gut microbiota is not a major factor that governs sus-
ceptibility to food borne listeriosis, as is the case for C. rodentium 
infection in mice.
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Myers-Morales  present results indicating that B6 or BALB mice depleted of gut flora usinget al.
streptomycin do not show altered resistance when given a fecal transplant from the opposing strain. The
studies suggest, but do not prove, that gut flora do not contribute to the differing resistance of these
strains.
A few concerns, if addressed, would strengthen the paper.
It is assumed that B6 and BALB mouse strains have differences in their streptomycin-resistant
flora. However, this was not actually established by the authors.
 
A control group with streptomycin treatment alone might establish whether depletion (not
"eradication," as stated) of the flora itself affected resistance. If so, the reconstitution apparently
restored the original phenotype regardless of donor. This or other more direct approaches could be
used to establish whether the transfer was successful at modifying the flora in recipients.
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The article “Fecal transplantation does not transfer either susceptibility or resistance to food borne
listeriosis in C57BL/6 and BALB/c/By mice” by Myers-Morales . demonstrates that the intestinalet al
microbiota is not a major determinant in the differences in susceptibility between C57BL/6 and BALB/c/By
mice. It is an important report of negative results.   
 A couple of clarifications are requested/suggested.  
 1)    While not necessary, the characterization of the microbial community in transplanted mice to confirm
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 1)    While not necessary, the characterization of the microbial community in transplanted mice to confirm
effective transfer would strengthen the claim. 
2)    The report by Willing . demonstrated that susceptibility in C3H/HeJ mice could be partiallyet al
transferred to resistant NIH Swiss mice, not completely. While higher colonization and increased
pathology was shown, the transfer of mortality phenotype was not demonstrated.
3)    The presentation of data for CFU counts should be normalized to weight. (CFU/g). CFU/organ or
CFU/fecal pellet would also be acceptable. 
4)    In the results section: Streptomycin depletes, but does not “eradicate” the microbiota.
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